_version_ 1785090430668374016
author Dussiau, Charles
Comont, Thibault
Knosp, Camille
Vergnolle, Ines
Bravetti, Clotilde
Canali, Alban
Houvert, Amandine
Largeaud, Laetitia
Daveaux, Christian
Zaroili, Laila
Friedrich, Chloe
Boussaid, Ismael
Zalmai, Loria
Almire, Carole
Beyne-Rauzy, Odile
Willems, Lise
Bouscary, Didier
Gandrillon, Olivier
Fontenay, Michaela
Kosmider, Oliver
Vergez, Francois
Chapuis, Nicolas
author_facet Dussiau, Charles
Comont, Thibault
Knosp, Camille
Vergnolle, Ines
Bravetti, Clotilde
Canali, Alban
Houvert, Amandine
Largeaud, Laetitia
Daveaux, Christian
Zaroili, Laila
Friedrich, Chloe
Boussaid, Ismael
Zalmai, Loria
Almire, Carole
Beyne-Rauzy, Odile
Willems, Lise
Bouscary, Didier
Gandrillon, Olivier
Fontenay, Michaela
Kosmider, Oliver
Vergez, Francois
Chapuis, Nicolas
author_sort Dussiau, Charles
collection PubMed
description
format Online
Article
Text
id pubmed-10428282
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104282822023-08-17 S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES Dussiau, Charles Comont, Thibault Knosp, Camille Vergnolle, Ines Bravetti, Clotilde Canali, Alban Houvert, Amandine Largeaud, Laetitia Daveaux, Christian Zaroili, Laila Friedrich, Chloe Boussaid, Ismael Zalmai, Loria Almire, Carole Beyne-Rauzy, Odile Willems, Lise Bouscary, Didier Gandrillon, Olivier Fontenay, Michaela Kosmider, Oliver Vergez, Francois Chapuis, Nicolas Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428282/ http://dx.doi.org/10.1097/01.HS9.0000967560.87989.c2 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Sessions
Dussiau, Charles
Comont, Thibault
Knosp, Camille
Vergnolle, Ines
Bravetti, Clotilde
Canali, Alban
Houvert, Amandine
Largeaud, Laetitia
Daveaux, Christian
Zaroili, Laila
Friedrich, Chloe
Boussaid, Ismael
Zalmai, Loria
Almire, Carole
Beyne-Rauzy, Odile
Willems, Lise
Bouscary, Didier
Gandrillon, Olivier
Fontenay, Michaela
Kosmider, Oliver
Vergez, Francois
Chapuis, Nicolas
S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
title S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
title_full S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
title_fullStr S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
title_full_unstemmed S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
title_short S162: LOSS OF HEMATOPOIETIC PROGENITORS HETEROGENEITY IS AN ADVERSE PROGNOSTIC FACTOR IN MYELODYSPLASTIC SYNDROMES
title_sort s162: loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in myelodysplastic syndromes
topic Oral Sessions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428282/
http://dx.doi.org/10.1097/01.HS9.0000967560.87989.c2
work_keys_str_mv AT dussiaucharles s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT comontthibault s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT knospcamille s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT vergnolleines s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT bravetticlotilde s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT canalialban s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT houvertamandine s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT largeaudlaetitia s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT daveauxchristian s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT zaroililaila s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT friedrichchloe s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT boussaidismael s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT zalmailoria s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT almirecarole s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT beynerauzyodile s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT willemslise s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT bouscarydidier s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT gandrillonolivier s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT fontenaymichaela s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT kosmideroliver s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT vergezfrancois s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes
AT chapuisnicolas s162lossofhematopoieticprogenitorsheterogeneityisanadverseprognosticfactorinmyelodysplasticsyndromes